---
url: https://www.servicesaustralia.gov.au/polycythemia-vera
title: Polycythemia vera - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:41:34.722Z
source: servicesaustralia.gov.au
---
# Polycythemia vera

The PBS subsidises ruxolitinib for patients with polycythemia vera.

## on this page

-   [Patient eligibility](#a1)
-   [Authority applications](#a2)
-   [More information](#a3)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with ruxolitinib under the _National Health Act 1953_, section 85 for patients at least 18 years of age with polycythemia vera.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home;jsessionid=jrrab7f28xtjycras12yiccu) on the PBS website outlines the restrictions for prescribing ruxolitinib.

## Authority applications

### Applying for initial treatment

Please note: You’ll get an immediate assessment when you request [PBS authorities online](/apply-for-pbs-authority?context=20#accordion1).

Applications for initial authority approval to prescribe PBS-subsidised ruxolitinib to treat polycythemia vera can be made in:

-   real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [polycythemia vera - ruxolitinib - initial authority application](/pb388?context=20)
-   relevant attachments.

Applications for balance of initial treatment (up to 48 weeks) can be made in real time using the Online PBS Authorities system or by phone. Call 1800 700 270 Monday to Friday, 8 am to 5 pm, local time.

### Applying for continuing treatment

#### Applying for the first continuing treatment

Applications for the first continuing authority approval to prescribe PBS-subsidised ruxolitinib to treat polycythemia vera can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

#### Applying for subsequent continuing treatment

Applications for subsequent continuing authority approval to prescribe PBS-subsidised ruxolitinib to treat polycythemia vera can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

## More information

Call the [PBS Co/node/35086mplex Drugs Programs enquiry line](/apply-for-pbs-authority?context=20) for more information.
